OneSubsea IP UK Limited v. FMC Technologies, Inc.
Before Clevenger, Moore, and Dyk. Appeal from the United States District Court for the Southern District of Texas.
Summary: Ordering additional discovery before ultimately...more
AMERICAN NATIONAL v. SLEEP NUMBER CORPORATION [OPINION]- PRECEDENTIAL -
Before Stoll, Schall, and Cunningham. Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2019-00497...more
Summary: Determining whether a patent or application’s disclosure is “by another” under § 102(e) requires evaluating the relied-upon portions of the disclosure to determine if the source of this disclosure is truly “by...more
ADAPT PHARMA OPERATIONS LTD. V. TEVA PHARMS. USA, INC.
Before Newman, Prost, and Stoll. Appeal from the United States District Court for the District of New Jersey.
Summary: Recent attempts by competitors to achieve...more
2/15/2022
/ Evidence ,
Generic Drugs ,
Intellectual Property Protection ,
Nonobvious ,
Objective Standard ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Teva Pharmaceuticals